Why a test for macular degeneration should be a standard in your examination

Patients with early stages of age-related macular degeneration (AMD) are often unaware of restrictions of their vision and, thus, the beginning disease.

1. HOW YOU CAN RECOGNIZE EARLY ABNORMALITIES IN THE MACULA BY USING THE MMT 2.0

As an optometrist, you should be able to take care of your clients’ vision for a life time.

You can create the basis for the timely detection of visual abnormalities by appropriate precautionary measurements. The Macular Mapping Test (MMT 2.0) can detect early effects of beginning age-related macular degeneration (AMD), including those outside the fovea (up to 10 deg eccentricity). Your clients usually do not recognize vision loss at this stage of the disease, which is why they may not notice the onset of the disease.
The Macular Mapping Test 2.0 helps to determine whether the results of your client’s examination are within the normal age standard. At the end, you receive a report for each eye that can be given to the client or, if necessary, to a specialist for further diagnosis.

2. TESTING RESIDUAL VISION WITH THE MMT 2.0

Clients with an already known diagnosis (AMD, diabetic retinopathy, etc.) also benefit from the Macular Mapping Test (MMT 2.0).

By running the test, you can quickly examine residual vision within the macular region and visualize it for the client. This helps you and the client to better understand symptoms (difficulties in reading etc.) and serves as a basis for subsequent recommendations, e.g. magnifying visual aids.

3. CONSULTING AND DOCUMENTATION WITH THE SIMPLE MMT 2.0 REPORT CHART

The clear depiction of results in the test report will help you with your documentation.

At the end of each test, you will receive a test report in pdf format, which can be stored, printed or forwarded easily. This simple form of documentation allows you to document a possible illness by regularly repeated measurements – even during an ongoing therapy.